Full Press Release Details
presentation may contain forward-looking statements, including statements
regarding the intent, belief or current expectations of Oramed Pharmaceuticals
Inc. and affiliates about the market, business, properties, financial condition
and results of operations of our 50% indirectly held subsidiary, Entera Bio Ltd.
Words such as "believe," "expect," "intend," "estimate," "target," "goal,"
variations of such words and similar expressions are intended to identify
forward-looking statements but are not the exclusive means of identifying such
statements. Actual results may differ materially from those projected, expressed
or implied in the forward-looking statements as a result of various factors
including, without limitation, the factors set forth in our filings with the
Securities and Exchange Commission including, without limitation, Item 1.A of
our annual report on Form 10-K for the fiscal year ended December 31, 2009,
under the caption "Risk Factors." Any forward-looking statements contained
herein speak only as of the date hereof, and we caution existing and prospective
investors not to place undue reliance on such statements. Such forward-looking
statements do not purport to be predictions of future events or circumstances,
and therefore, there can be no assurance that any forward-looking statement
contained our releases will prove to be accurate. We undertake no obligation to
update or revise any forward-looking statements. All subsequent written or oral
forward-looking statements attributable to us or persons acting on our behalf
are expressly qualified in their entirety by the cautionary statements set forth
in our filings with the Securities and Exchange Commission including, without
limitation, Item 1.A of our annual report on Form 10-A for the fiscal year ended
December 31, 2009, under the caption "Risk Factors."
material herein is proprietary to Oramed Pharmaceuticals Inc. and any
unauthorized reproduction of any part thereof is strictly
herein constitutes an offer to purchase or solicitation to sell securities of
Oramed Pharmaceuticals Inc. or of Entera Bio Ltd.